FDA Plans to Regulate Genetic Health Tests as Class II Devices

The GMP Letter
A A
The FDA has classified genetic health risk assessment systems as Class II with special controls, and is proposing to exempt the devices from premarket reviews.

To View This Article:

Login

Subscribe To The GMP Letter